More on CNXU
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.51 |
|
|||
| Open | $10.29 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $10.29 | ||||
| Day Low | $9.45 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 93,234 | ||||
- A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next
- The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
- Form 8-K Conexeu Sciences Inc. For: Jul 07
- A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
- A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
- Form D Conexeu Sciences Inc.
- Form D Conexeu Sciences Inc.
- Form 3 Conexeu Sciences Inc. For: Jun 15 Filed by: Costa Andrew
- The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
- Conexeu Sciences opens R&D lab at Vancouver's adMare M4 centre
Entities mentioned with CNXU
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Morgan Stanley | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
